Rheumatologists News and Research

RSS

EULAR project reveals large disparities in European rheumatology care

Rheumatic and musculoskeletal diseases (RMD) are responsible for significant disability, and result in long-term work loss or early retirement.

1 Jul 2026

Patient organizations strengthen support for people with rheumatic diseases

Rheumatic and musculoskeletal diseases (RMD) are chronic, often lifelong conditions. EULAR - The European Alliance of Associations for Rheumatology - works with the network of national organizations of People with Arthritis/Rheumatism in Europe (PARE) to ensure the voices of people with RMD are heard and have influence among decision makers - creating powerful alliances that make a real difference to lives.

7 Jun 2026

EULAR 2026 highlights rising comorbidity risks in rheumatic disease

People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular diseases to cognitive impairment and fractures.

4 Jun 2026

FDA clears investigational new drug application to test sCAR-T therapy for autoimmune conditions

Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions.

10 Apr 2026

Updated EULAR recommendations guide treatment decisions for rheumatoid arthritis

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease, have been relied upon by healthcare professionals and organisations worldwide to offer an up-to-date and robust analysis of the effectiveness and practical use of available DMARDs – from conventional agents such as methotrexate to biologics and Janus kinase (JAK) inhibitors.

13 Mar 2026

Skin-delivered estrogen improves bone health in amenorrhoa

Hormone replacement therapy applied via the skin is the best way of protecting bone density in women whose periods have stopped due to anorexia or intense exercise, according to new research from Imperial College London and Imperial College Healthcare NHS Trust.

6 Feb 2026

TikTok videos about gout often contain misleading information

A new paper in Rheumatology Advances in Practice, published by Oxford University Press, indicates that TikTok videos about gout are commonly misleading, inconsistent, or inaccurate.

11 Dec 2025

UCI Health launches clinical trial to test investigational cell therapy for lupus

UCI Health has opened a clinical trial to test an investigational cell therapy for lupus with the potential to give patients long-term remission of symptoms.

17 Nov 2025

Health care cuts threaten homegrown solutions to rural doctor shortages

Olivia Owlett chose to do her primary care residency in this Northern California college town largely because it faces many of the same health care challenges she grew up with.

18 Sep 2025

New guidelines for managing interstitial lung disease associated with connective tissue diseases

EULAR - The European Alliance of Associations for Rheumatology - has worked with the European Respiratory Society (ERS) to develop new clinical practice guidelines for interstitial lung disease (ILD) associated with connective tissue diseases (CTD).

5 Sep 2025

Recombinant zoster vaccine well tolerated by patients with inflammatory RMD

Herpes zoster (HZ) is common in older people, with a lifetime risk of 25%. The main risk factors are advanced age and immunosuppression. People with a rheumatic and musculoskeletal disease have an overall higher risk for shingles.

11 Jun 2025

Residual inflammation can linger in psoriasis patients despite skin treatment

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, inflammation can linger, leading to broader health implications such as obesity and cardiovascular and fatty liver disease.

20 May 2025

Comprehensive treatment approach helps patients manage rheumatoid arthritis

Although rheumatoid arthritis is an autoimmune disease with no cure, a tailored, multidisciplinary treatment approach at Cedars-Sinai's Inflammatory Arthritis Clinical Center helps patients get back to the activities they enjoy.

7 May 2025

New recommendations for the treatment of familial Mediterranean fever

In 2016, EULAR - The European Alliance of Associations for Rheumatology - published recommendations on the treatment of familial Mediterranean fever (FMF). Since then, new evidence has become available, so the recommendations have been reviewed and updated.

23 Apr 2025

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases

9 Apr 2025

Corticosteroid use linked to higher risk of lupus pericarditis recurrence

A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart complication of the autoimmune disease Systemic Lupus Erythematosus (SLE).

26 Feb 2025

Young people with chronic pain more likely to have clinical anxiety or depression

Young people with chronic pain are three times more likely than their peers to also have clinical anxiety or depression, a new review has found.

9 Sep 2024

Engineered heart tissues uncover new mechanisms in lupus-related heart damage

Cardiovascular disease is the leading cause of death in patients suffering from lupus, an autoimmune disease in which our immune system attacks our own tissues and organs, the heart, blood, lung, joints, brain, and skin.

20 Aug 2024

EULAR unveils ambitious 2024-2029 European Manifesto to combat rheumatic diseases

The European Alliance of Associations for Rheumatology (EULAR) is proud to announce the launch of its 2024 - 2029 European Manifesto, aimed at addressing the urgent need for a coordinated European response to Rheumatic and Musculoskeletal Diseases (RMDs), focusing particularly on the areas of quality of care, research, and social policy.

14 Jun 2024

New points-to-consider in the diagnosis, treatment of systemic hyperinflammatory syndromes

Hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) are life-threatening systemic hyperinflammatory syndromes.

5 Feb 2024